Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort, 85221 [2024-24833]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices
presentations with audio and video
components to allow the presentation of
materials for online participants in a
manner that most closely resembles an
in-person advisory committee meeting.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the Committee. All electronic and
written submissions to the Docket (see
ADDRESSES) on or before November 19,
2024, will be provided to the
Committee. Oral presentations from the
public will be scheduled following FDA
presentations. FDA has allotted
approximately 1 hour for open public
hearing presentations, which will be
split to allow for public remarks on each
substance. The sessions will begin at
approximately 9:35 a.m., 10:50 a.m., and
1:40 p.m. Those individuals interested
in making formal oral presentations
should notify the contact person and
submit a brief statement of the general
nature of the evidence or arguments
they wish to present, the names and
addresses of proposed participants,
whether they would like to present
online or in-person, and an indication of
the approximate amount of time
requested to make their presentation on
or before November 8, 2024. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. FDA may also
extend the time scheduled for open
public hearing presentations depending
on interest. Similarly, room for
interested persons to participate inperson may be limited. If the number of
registrants requesting to speak in-person
during the open public hearing is
greater than can be reasonably
accommodated in the venue for the inperson portion of the advisory
committee meeting, FDA may conduct a
lottery to determine the speakers who
will be invited to participate in-person.
The contact person will notify
interested persons regarding their
request to speak and the timeframe for
the presentation by November 12, 2024.
Persons attending FDA’s advisory
committee meetings are advised that
FDA is not responsible for providing
access to electrical outlets.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
VerDate Sep<11>2014
17:40 Oct 24, 2024
Jkt 265001
disability, please contact Takyiah
Stevenson (see FOR FURTHER
INFORMATION CONTACT) at least 7 days in
advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. 1001 et seq.). This meeting notice
also serves as notice that, pursuant to 21
CFR 10.19, the requirements in 21 CFR
14.22(b), (f), and (g) relating to the
location of advisory committee meetings
are hereby waived to allow for this
meeting to take place using an online
meeting platform in conjunction with
the physical meeting room (see
location). This waiver is in the interest
of allowing greater transparency and
opportunities for public participation,
in addition to convenience for advisory
committee members, speakers, and
guest speakers. The conditions for
issuance of a waiver under 21 CFR 10.19
are met.
Dated: October 21, 2024.
Eric Flamm,
Acting Associate Commissioner for Policy.
[FR Doc. 2024–24828 Filed 10–24–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Final Effect of Designation of a Class
of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
HHS gives notice concerning
the final effect of the HHS decision to
designate a class of employees from the
Metals and Controls Corp. in Attleboro,
Massachusetts, as an addition to the
Special Exposure Cohort (SEC) under
the Energy Employees Occupational
Illness Compensation Program Act of
2000.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Grady Calhoun, Director, Division of
Compensation Analysis and Support,
NIOSH, 1090 Tusculum Avenue, MS C–
46, Cincinnati, OH 45226–1938,
Telephone 513–533–6800. Information
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
85221
requests can also be submitted by email
to DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION: On
September 9, 2024, as provided for
under 42 U.S.C. 7384l(14)(C), the
Secretary of HHS designated the
following class of employees as an
addition to the SEC:
All atomic weapons employees who
worked at Metals and Controls Corp. in
Attleboro, Massachusetts, from January 1,
1968, through September 21, 1995, for a
number of work days aggregating at least 250
work days, occurring either solely under this
employment or in combination with work
days within the parameters established for
one or more other classes of employees
included in the SEC.
This designation became effective on
October 9, 2024. Therefore, beginning on
October 9, 2024, members of this class of
employees, defined as reported in this notice,
became members of the SEC.
Authority: 2 U.S.C. 384q(b). 42 U.S.C.
7384l(14)(C).
John J. Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2024–24833 Filed 10–24–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Innovation Research/Small
Business Technology Transfer: Clinical Care
and Health Interventions.
Date: November 14–15, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: In Person and Virtual
Meeting.
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Page 85221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Final Effect of Designation of a Class of Employees for Addition
to the Special Exposure Cohort
AGENCY: National Institute for Occupational Safety and Health (NIOSH),
Centers for Disease Control and Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HHS gives notice concerning the final effect of the HHS
decision to designate a class of employees from the Metals and Controls
Corp. in Attleboro, Massachusetts, as an addition to the Special
Exposure Cohort (SEC) under the Energy Employees Occupational Illness
Compensation Program Act of 2000.
FOR FURTHER INFORMATION CONTACT: Grady Calhoun, Director, Division of
Compensation Analysis and Support, NIOSH, 1090 Tusculum Avenue, MS C-
46, Cincinnati, OH 45226-1938, Telephone 513-533-6800. Information
requests can also be submitted by email to [email protected].
SUPPLEMENTARY INFORMATION: On September 9, 2024, as provided for under
42 U.S.C. 7384l(14)(C), the Secretary of HHS designated the following
class of employees as an addition to the SEC:
All atomic weapons employees who worked at Metals and Controls
Corp. in Attleboro, Massachusetts, from January 1, 1968, through
September 21, 1995, for a number of work days aggregating at least
250 work days, occurring either solely under this employment or in
combination with work days within the parameters established for one
or more other classes of employees included in the SEC.
This designation became effective on October 9, 2024. Therefore,
beginning on October 9, 2024, members of this class of employees,
defined as reported in this notice, became members of the SEC.
Authority: 2 U.S.C. 384q(b). 42 U.S.C. 7384l(14)(C).
John J. Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 2024-24833 Filed 10-24-24; 8:45 am]
BILLING CODE 4163-18-P
